Recursion Pharmaceuticals (RXRX) Return on Assets [ROA] (2021 - 2026)
Recursion Pharmaceuticals (RXRX) reported Return on Assets [ROA] of -40.66% for Q2 2026, up 9.13 percentage points from -49.79% a year earlier but down 0.87 percentage points from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Recursion Pharmaceuticals posted Return on Assets [ROA] of -44.12%, down 0.01 percentage points from FY2024.
- Return on Assets [ROA] has a four-year change of -3.09 percentage points (FY2021 to FY2025).
- By year, Return on Assets [ROA] came in at -44.11% in FY2024 (+4.31 pp), -48.42% in FY2023 (-11.91 pp), -36.52% in FY2022 (+4.52 pp) and -41.03% in FY2021.
- Five-year quarterly Return on Assets [ROA] spans a low of -58.46% in Q1 2024 and a high of -21.13% in Q3 2021.
- Year over year, Return on Assets [ROA] gained in five of the last eight quarters, with an average year-over-year change of +4.14 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q1 2025 (a gain of 16.71 percentage points); the low point was Q1 2024 (a drop of 20.06 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -39.79% (Q1 2026), -44.87% (Q4 2025) and -52.97% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Recursion Pharmaceuticals | 2.20 Bn | -402.71 Mn | -3.82 Mn | -40.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.66% |
| Mar 31, 2026 | -39.79% |
| Dec 31, 2025 | -44.87% |
| Sep 30, 2025 | -52.97% |
| Jun 30, 2025 | -49.79% |
| Mar 31, 2025 | -41.74% |
| Dec 31, 2024 | -42.63% |
| Sep 30, 2024 | -50.29% |
| Jun 30, 2024 | -56.22% |
| Mar 31, 2024 | -58.46% |
| Dec 31, 2023 | -51.08% |
| Sep 30, 2023 | -45.63% |
| Jun 30, 2023 | -41.05% |
| Mar 31, 2023 | -38.40% |
| Dec 31, 2022 | -37.43% |
| Sep 30, 2022 | -38.89% |
| Jun 30, 2022 | -33.20% |
| Mar 31, 2022 | -30.98% |
| Dec 31, 2021 | -28.81% |
| Sep 30, 2021 | -21.13% |
API Access
Recursion Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();